ArticleThe Journal of infection2022
Prospective surveillance of human adenovirus in acute respiratory infections reveals epidemiological features and the disappearance of species B during the COVID-19 pandemic in Beijing, China.
Open access · greenAbstract readLetter
In one paragraph
Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 22 citations in OpenAlex.
- First detection of human adenovirus type 7 deletion mutant associated with an outbreak of acute respiratory infection.Virology journal · 2026Article
- Dynamic Shifts in Respiratory Pathogens During the First Post-COVID-19 Autumn-Winter in Beijing.International journal of general medicine · 2026Article
- Molecular characteristics of human adenovirus isolated from the 2024 influenza-like illness outbreaks in Suzhou City, China.Virology journal · 2025Article
- Whole genome-based surveillance for human adenovirus-related diseases in Kobe City, Japan, 2018-2022.BMC research notes · 2025Article
- Epidemiological characteristics and genomic analysis of respiratory adenovirus in Lanzhou City from 2023 to 2025.Frontiers in cellular and infection microbiology · 2025Article
- Respiratory virus behavior: Results of laboratory-based epidemiological surveillance.PloS one · 2024Article
- Influence of COVID-19 pandemic on the virus spectrum in children with respiratory infection in Xuzhou, China: a long-term active surveillance study from 2015 to 2021.BMC infectious diseases · 2023Article
- The changed endemic pattern of human adenovirus from species B to C among pediatric patients under the pressure of non-pharmaceutical interventions against COVID-19 in Beijing, China.Virology journal · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 2 institutions in 1 country.
Maozhong LiBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Qin LuoBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China; College of Public Health, Capital Medical University, Beijing 100069, China.
Cheng GongBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Ai Hua LiBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Mei DongBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Herun ZhangBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Xue WangBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Ming LuoBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Yiting WangBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Hui XieBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Lu KangBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China.
Qi HuangBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China; College of Public Health, Capital Medical University, Beijing 100069, China.
Lili RenNational Health Commission of the People's Republic of China Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, No.9 Dong Dan San Tiao, Dongcheng, Beijing 100730, China; Key Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, PR China. Electronic address: renliliipb@163.com.
Fang HuangBeijing Center for Disease Control and Prevention/Beijing Academy for Preventive Medicine/Beijing Institute of Tuberculosis Control Research and Prevention, Institute for immunization and prevention, No.16 Hepingli Middle Street, Dongcheng, Beijing 100013, China; College of Public Health, Capital Medical University, Beijing 100069, China. Electronic address: hhffxdd@126.com.
Beijing Center for Disease Prevention and Control · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Adenoviruses, HumanCOVID-19Respiratory Tract InfectionsBeijingChinaHumansInfantPandemicsProspective Studies
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.